NCT05899608 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05899608
Title	Clinical Study of Ivonescimab for First-line Treatment of Metastatic Squamous NSCLC Patients
Recruitment	Recruiting
Gender	both
Phase	Phase III
Variant Requirements	Yes
Sponsors	Summit Therapeutics
Indications	lung squamous cell carcinoma lung non-small cell carcinoma lung non-squamous non-small cell carcinoma
Therapies	Pembrolizumab Ivonescimab
Age Groups:	senior \| adult
Covered Countries	USA \| SWE \| POL \| ITA \| IRL \| GRC \| GBR \| FRA \| ESP \| DEU \| CAN \| BEL

NCT05899608
Clinical Trial Detail